Peptide Improves Cognition in Schizophrenia

Estimated read time 1 min read

This shows neurons.Researchers developed a novel peptide, KS-133, to target cognitive dysfunction in schizophrenia. By using a brain-targeting peptide, KS-487, they successfully transported KS-133 across the blood-brain barrier. Their nanoparticle-based drug delivery system improved cognitive functions in mice, offering a new therapeutic strategy.

You May Also Like

More From Author

+ There are no comments

Add yours